Hypoxic-ischemic brain injury in the perinatal period is a major cause of morbidity and mortality. Presently, there are no proven effective therapies with which to safeguard the human neonatal brain against this type of injury. Minocycline, a semisynthetic tetracycline, has been shown to be neuropro
Nerve growth factor protects the neonatal brain against hypoxic–ischemic injury
✍ Scribed by Dr. David M. Holtzman; R. Ann Sheldon; Wyatt Jaffe; Yu Cheng; Donna M. Ferriero
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 1018 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Developing oligodendrocytes (pre‐OLs) are highly vulnerable to hypoxic‐ischemic injury and associated excitotoxicity and oxidative stress. 17β‐Estradiol plays an important role in the development and function of the CNS and is neuroprotective. The sudden drop in circulating estrogen aft
## Abstract Minocycline is a second‐generation tetracycline and a potential neuroprotective intervention following brain injury. However, despite the recognized beneficial effects of minocycline in a multitude of adult disease states, the clinical application of minocycline in neonates is contentio
Iron can contribute to hypoxic-ischemic brain damage by catalyzing the formation of free radicals. The immature brain has high iron levels and limited antioxidant defenses. The objective of this study was to describe the early alterations in nonheme iron histochemistry following a hypoxic-ischemic (
## Abstract We examined the effect of treatment with intraventricular injection of a decoy oligonucleotide that binds and inhibits nuclear factor‐κB on cytokine expression, ICAM‐1 expression, neutrophil recruitment, apoptosis, and tissue injury in a model of neonatal hypoxic‐ischemic cerebral injur